CTLA4 and hepatocellular carcinoma: The high frequency of GARP+/CTLA4+ Tregs (Figure 1) in patients with advanced hepatocellular carcinoma (HCC) may facilitate immune dysregulation, and the expression levels of GARP and CTLA were not associated with the viral infection.